Genetic Counseling Sequence for Heart Disease
(RESEQUENCEGC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods for providing genetic counseling to individuals with potential hereditary heart diseases. The goal is to determine if conducting most counseling after genetic test results can make the process more efficient and empowering for patients. Participants will be divided into three groups: one receiving standard pre-test counseling, another receiving video-based education with optional phone calls with a genetic counselor, and a third receiving video education with required pre-test phone calls with a genetic counselor. Ideal participants are adults referred for genetic counseling at Johns Hopkins for suspected or confirmed inherited heart conditions. As an unphased trial, this study offers participants the chance to contribute to innovative approaches in genetic counseling, potentially enhancing future patient experiences.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on genetic counseling and testing for heart disease, so it's best to discuss your medications with the trial team.
What prior data suggests that this genetic counseling sequence is safe for cardiovascular patients?
Research shows that genetic counseling, whether in person or over the phone, is generally safe and well-received by participants. Studies indicate that phone calls with a genetic counselor usually do not cause negative emotional or mental reactions. Many people find it convenient to discuss their genetic test results over the phone.
Research highlights the effectiveness of video-based education before the test, followed by counseling after the test, in making complex genetic information easier to understand. This method has been used in other situations and supports patients well.
Overall, the treatments in this trial, which include optional or required phone calls and video education, are well-tolerated. They aim to help participants understand their genetic information without causing stress or confusion.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to provide genetic counseling for heart disease, potentially enhancing patient experience and understanding. The "Efficiency" approach offers flexible learning by combining a video with an optional pre-test call, allowing patients to address concerns at their convenience. The "Flipped" method goes a step further by requiring a pre-test call, ensuring that patients engage directly with a genetic counselor to clarify any questions. These methods could make genetic counseling more accessible and personalized, which is a step up from the standard of care where patients usually have a scheduled pre-test counseling session followed by results through phone or electronic records.
What evidence suggests that this trial's treatments could be effective for heart disease?
Research has shown that genetic counseling before and after testing is important and recommended in disease guidelines. Studies have found that clear communication during these sessions helps patients understand their results better and improves health outcomes. In this trial, participants in the "Efficiency" arm can opt for a phone call with a genetic counselor to ask specific questions and express concerns, leading to better engagement and satisfaction. Participants in the "Flipped" arm will have a required phone call with a genetic counselor, ensuring personalized support for informed healthcare decisions. After testing, counseling helps patients understand complex genetic information and apply it to their healthcare, empowering them and encouraging adherence to medical advice. Overall, these counseling methods aim to make genetic testing more effective and beneficial for patients with heart disease.34678
Who Is on the Research Team?
Cynthia James
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
Adults over 18 with suspected or diagnosed inherited heart conditions, including various cardiomyopathies, arrhythmias, lipid disorders, or early-onset coronary artery disease. They must be scheduled for genetic counseling at the Johns Hopkins Center and have not had previous genetic counseling/testing for their condition there.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-test Education
Participants receive pre-test genetic education via an educational video, with an optional or required call with a genetic counselor depending on the study arm
Post-test Genetic Counseling
Participants receive post-test genetic counseling to discuss test results and implications
Follow-up
Participants are monitored for anxiety, engagement, empowerment, and medical adherence
What Are the Treatments Tested in This Trial?
Interventions
- optional phone call with genetic counselor pre-test
- post-test cardiovascular genetic counseling with pre-test education by video
- required phone call with genetic counselor pre-test
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Human Genome Research Institute (NHGRI)
Collaborator